
























The	 glucocorticoid	 hormone	 cortisol	 acts	 throughout	 the	 body	 to	 support	 circadian	
processes	and	adaptation	to	stress.	The	glucocorticoid	receptor	is	the	target	of	cortisol	
and	of	synthetic	glucocorticoids,	which	are	used	widely	in	the	clinic.	Both	agonism	and	
antagonism	 of	 the	 glucocorticoid	 receptor	may	 be	 beneficial	 in	 disease,	 but	 given	 the	
wide	expression	of	the	receptor	and	involvement	in	various	processes,	beneficial	effects	
are	 often	 accompanied	 by	 unwanted	 side	 effects.	 Selective	 glucocorticoid	 receptor	
modulators	 are	 ligands	 that	 induce	 a	 receptor	 conformation	 that	 allows	 activation	 of	
only	 a	 subset	 of	 downstream	 signalling	 pathways.	 Such	 molecules	 thereby	 combine	
agonistic	 and	 antagonistic	 properties.	 Here	 we	 discuss	 the	 mechanisms	 underlying	
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Figure 1. Left hand side: GR may bind to the DNA either directly, via GREs, or via 
protein-protein interactions with transcription factors like NF-kB. ‘Dissociated 
ligands’ favor the latter interaction, which results in fewer side effects, but also loss 
of antiinflammatory efficacy. 
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